CBZ 0.00% 5.2¢ cbio limited

cbio, page-8

  1. 235 Posts.
    lightbulb Created with Sketch. 51
    Katy, I read that a phase 2a trial for Crohn's Disease was scrapped in 2005 due to slow recruitment. As a long termer, do you recall why there was a lack of interest? What a pity. I am really looking forward to the possibilities of future trials in the hope of alleviating suffering from other auto-immune disorders - and there are so many of them...
 
watchlist Created with Sketch. Add CBZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.